Autonomix Medical, Inc. Common Stock (AMIX) NASDAQ
0.32
-0.00740001(-2.25%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
0.32
-0.00740001(-2.25%)
Currency In USD
| Previous Close | 0.33 |
| Open | 0.33 |
| Day High | 0.33 |
| Day Low | 0.32 |
| 52-Week High | 2.64 |
| 52-Week Low | 0.32 |
| Volume | 51,946 |
| Average Volume | 141,979 |
| Market Cap | 1.66M |
| PE | -0.1 |
| EPS | -3.15 |
| Moving Average 50 Days | 0.39 |
| Moving Average 200 Days | 0.74 |
| Change | -0.01 |
Autonomix Medical to Present at LSI USA ’26
GlobeNewswire Inc.
Mar 11, 2026 12:40 PM GMT
THE WOODLANDS, TX, March 11, 2026 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company dedicated to advancing precision nerve-targeted treatments, today announced that Brad Hauser, Presi
Autonomix Medical Selected for Best Innovation Competition at CRT 2026
GlobeNewswire Inc.
Mar 05, 2026 1:45 PM GMT
THE WOODLANDS, TX, March 05, 2026 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company dedicated to advancing precision nerve-targeted treatments, today announced that its presentation
Autonomix Medical Selected as Top Abstract at CRT 2026 and Selected for Podium Presentation of Clinical Feasibility and Outcomes of Novel Technique for Transvascular Peripheral RF Nerve Neurolysis
GlobeNewswire Inc.
Mar 04, 2026 1:40 PM GMT
THE WOODLANDS, TX, March 04, 2026 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company dedicated to advancing precision nerve-targeted treatments, today announced that Nikola Cesarovic,